Traders spoke of a "lost year 2017." Morphosys stocks fell about 8.5 percent - but had posted significant gains in the previous week.

It will be exciting again for investors on Wednesday. Then the US Federal Reserve will announce its latest interest rate decision. Source: ntv.de, bad / DJ "The costly development of new drugs increases the loss at the biotech company Morphosys. The operating loss (EBIT) rose to 14.9 in the first quarter Million euros from a minus of 9.7 million euros a year ago.

Sales fell by 2.5 percent to 11.8 million euros. This development does not come as a surprise, as Morphosys announced a long time ago that it would spend significantly more money on researching new drugs. Morphosys hopes that its licensing partner Janssen - a subsidiary of the US pharmaceutical and consumer goods company Johnson Johnson - will receive approval for the psoriasis drug guselkumab in the USA this year. Then Morphosys would wave a milestone payment and an annual revenue share in the mid-single-digit percentage range. (rts) Source: ntv.de "The first pre-Easter surprise has succeeded: There are big profits on the German stock market. (Photo: picture-alliance / dpa / dpaweb) As lossy Tuesday, so profitable Wednesday: The German stock market is celebrating Return of the buying mood. The necessary impetus is provided by quarterly reports and economic data alike. A "recovery movement" on the German stock market on Wednesday makes the bitter losses on Tuesday forget.

This is due to economic data from China and lots of quarterly reports from the USA. Even a few negative US economic data could not dampen the positive mood of German investors. The Dax closed at the daily high of 9,317.82 points, 1.6 percent stronger. The MDax jumped 2.0 percent and went out of business with 15,970.99 digits. The TecDax showed the clearest gains, rising by 2.7 percent to 1,187.51 points - driven by positive indications from the Nasdaq, which in turn was fueled by several high-tech stocks that were positively received by quarterly reports unusual economic data from China: In the first quarter the gross domestic product rose by 7.4 percent and thus a little more than expected. However, the value was below the 7.5 percent targeted by the Chinese government for the full year.

In Asia, prices reacted with a rise across the board. Inflation in the euro zone became just as negligible as building permits in the USA. Both dates hardly burdened. The increase in US industrial production in March and the associated improved capacity utilization also fizzled out. "There was no reaction in the stock market," said one trader. That is "a little amazing".

The Fed's economic report, known as the Beige Book, only followed after the stock market closed, while only Adidas closed the Dax with losses.college biology essay writing services The sporting goods company's title slipped dormant 0.7 percent, with the strongest winners being Tuesday's top losers. Commerzbank gained 2.6 percent. Only Continental were topped, with a jump of 5.2 percent. The positively received Intel numbers pushed the Infineon papers forward. The titles gained 2.3 percent. The car values ​​were also in demand again: BMW moved up 2.5 percent, Daimler 2.1 percent and VW 2.4 percent.

At Volkswagen, Scania was once again on the agenda. At Daimler, fresh billions of euros in the coffers had a positive effect: The exit from the engine manufacturer Rolls-Royce Power Systems (formerly Tognum) washed 2.43 billion euros into the carmaker's coffers. SAP shares also tended to be friendly. The group was the first Dax company to publish quarterly figures on Thursday.

Morgan Stanley sees the orders for cloud services as the fastest growing segment in the focus of market interest: "SAP has proclaimed the strategy 'Cloud First' and therefore the figures in the cloud segment should be decisive, said the analyst Adam Wood. The consensus estimate for the cloud - Sales in the first quarter amounted to 218 million euros. That would be an increase of around 30 percent compared to the same quarter of the previous year. Around 80 percent of cloud orders would be made in the USA. "The numbers (in the cloud segment) should at least meet expectations meet, then that should further support the share price. "The shares closed 1.6 percent in the plus. The focus was also on the stocks of RWE. The utility had invited to the general meeting.

Protests from Verdi about the planned job cuts included. RWE papers were unimpressed, advancing 1.0 percent. Dealers saw no negative impact on the pesticide division of Bayer in Syngenta's business figures. The Swiss chemical company started the year somewhat weaker on the US market, but attributes this to the particular weather problems.

Accordingly, unimpressed, Bayer prices rose by 1.6 percent. Dealers described Gea's business figures for the first quarter as somewhat below expectations. Although sales have increased, at 951 million euros they are over 50 million euros below market expectations. Incoming orders also weakened slightly. "However, sales have still increased, the full year targets have been confirmed and the sale of the heat exchanger division is certainly the bigger story today," said one dealer. With a premium of 6.2 percent, Gea was also the top winner in the MDax, followed by ProSiebenSat.1. The reason: a positive analyst vote.

The titles climbed by 5.0 percent. Citigroup analysts had received their sell recommendation and advised their customers to weight the shares neutrally. The valuation is fair after the recent price slide.

The shares had previously lost almost 18 percent since the beginning of the year. According to a positive analyst comment from Deutsche Bank, Morphosys were also in great demand. The stocks of the biotech company jumped 11.8 percent in the TecDax. The latest price slide is unjustified and the entry point is currently attractive, the analysts wrote. Above all, they see potential in the antibody product pipeline.

The experts raised the price target for Morphosys to 81 from 64 euros and reiterated their buy recommendation for the stocks, which closed at 62.00 euros, followed by BB Biotech 6.0 percent and QSC 5.9 percent. Source: ntv.de , bad / DJ "The Dow can look back on four record highs and seven trading days with premium in a row. Profit-taking is logical. The Dax is falling - without any major price successes before that. The annual high is moving away, Bayer is partly to blame." One has the impression that that the Dax is not necessarily the crispest biscuit in a can. "That is the appropriate comment by n-tv stock market expert Frank Meyer on the current situation on the German stock market If it breaks out of its sideways range, which has lasted for months, this dream should be over for the time being with the losses on Wednesday. The Dax closed 0.7 percent weaker at 10,664 points.

It marked the day's low at 10,610 points and the day's high at 10,735 points. On Tuesday it went out of trading with a plus, but the premium came towards the end of trading. The MDax said goodbye to trading with 20,463 points, 0.6 percent in the red. The TecDax, on the other hand, gained 1.1 percent to 1717 points. About a week after the US election, attention shifted back to the monetary policy of the Federal Reserve (Fed). From the appearances of leading US central bankers, the stock exchange traders hope for clues as to how quickly the Fed will raise interest rates in the coming year.

A rate hike in December is already priced in at around 80 percent on the market. At the same time, the Trump rally on Wall Street and the lagging behind the Dax showed a blatant relative weakness, said a trader. That could be a first signal that German stocks could be among the underperformers in the future, given the "America First" measures announced in the Trump election campaign. Trust the brand. According to one market participant, the index could then break out of the sideways movement that has been going on for months. Overcoming it is also becoming more and more important, since the US stock exchanges have already succeeded, he underlined. Should the Dax finally crack the 10,800, "then the cow could fly", Meyer commented in the morning. The Dax companies were focusing on capital measures.

Bayer launched a mandatory convertible bond of over 4 billion euros. It was expected because of the Monsanto purchase. When the third quarter figures were published, Bayer had already indicated that the deal would be financed quickly. Bayer shares fell by more than 5 percent at times, then closed at a discount of more than 4 percent.

Together with Lufthansa, the papers were the biggest loser in the leading index. The analysts' period of silence ended at the RWE subsidiary Innogy. Goldman Sachs, UBS and Barclays rated the shares rather neutral, while Berenberg issued a buy recommendation. Innogy attracted around 2.5 percent.

RWE, the top winner on Tuesday, rose, fell and ended up closing around 1.5 percent more tightly. VW showed a similar picture. Here, too, things went up and down. At the end of trading, VW shares were down 0.7 percent. Volkswagen and Audi may have to shoulder significantly higher costs to resolve the emissions fraud scandal in the US. At least two class actions against Audi have been filed in federal courts in Illinois and Minnesota.

They accuse Audi of having defrauded customers by showing the values ​​for carbon dioxide emissions and fuel consumption for several of the most popular sedans and SUVs too low. According to traders, profit-taking burdened Leoni, the shares plummeted around 12 percent. However, they had reached an annual high on Tuesday. In addition, the company "only" reiterated its profit forecast for 2017: "Very few people on the market expect an EBIT of only 65 million euros," said one dealer. Hugo Boss also saw a downward trend. The losses were at times more than 13 percent, in the end the discount was around 10 percent.

The company had commented on the group restructuring. Traders spoke of a "lost year 2017." Morphosys stocks fell about 8.5 percent - but had posted significant gains in the previous week. The company had placed 2.6 million new shares in a private placement with investors at EUR 44.

According to the market, the 9 percent discount to the closing price on Tuesday was mainly due to the purchase of shares in biotech stocks in view of Trump's election victory. Wirecard gained 7 percent. You were the biggest TecDax winner. The forecast of an Ebitda of 382 to 400 million euros in the coming year is likely to surpass the previous analyst estimates for the most part: "Only the bulls on the market expect a profit around this level," said a trader.

The US stock exchanges did not find a unified direction. A week after Donald Trump's election victory, investors are puzzling over the US economic policy, which weighed on the Dow Jones. However, the technology sector benefits from this. Brad McMillan, chief investment strategist at the Commonwealth Fund, said that a reality check was now taking place after the surprise Republican election. "The markets have risen significantly since the election and now it is time for a review.

Did we go too far too fast? "The Dow Jones Standard Index fell 0.3 percent to close at 18,868 points. It had risen for seven days in a row and hit a record high. The broader SP-500 fell also by 0.3 percent to 2174. In contrast, the index of the technology exchange Nasdaq gained 0.4 percent to 5295 positions.Many market participants would hold back even before the important meeting of the US Federal Reserve in mid-December, it was said on the market Experts expect the Fed to then raise key rates.

The US monetary watchdog James Bullard said that a single rate hike could be enough to achieve a neutral monetary policy that no longer stimulates the economy. The move could take place as early as December. Many experts assume that the future president will soon open the treasury - in the form of tax cuts and investments in infrastructure. Investors' sales lists were mainly financial stocks.

Trump's announcement that he would like to regulate the banks less tightly caused a rally. Investors should take profits and first wait to see whether the election promises are actually implemented, according to an investment study by broker Baird. The biggest drop was JPMorgan's shares, down 3 percent, while Apple rose 3.2 percent - the highest increase since the election. The target was also the focus of the individual values.

The share of the retail chain rose 7.2 percent after the quarterly profit was surprisingly high and the forecast for the full year was raised. The euro could not stop its slide of the past trading days and fell to its lowest level in almost a year. The common currency cost $ 1.0684 late in the evening. It was 0.4 percent below the value on Tuesday evening. The European Central Bank (ECB) set the reference rate in the afternoon at $ 1.0702 after $ 1.0765 on Tuesday. Since Trump's victory in the US presidential election, the value of the US currency has risen against many other currencies.

Investors assume that Trump as President could massively increase government spending and cause higher inflation. This could possibly result in faster rate hikes by the US Federal Reserve. The prospect of rising interest rates is giving the dollar a boost.

However, it is still unclear to experts whether and to what extent the dollar's strength will continue. Many analysts point out that Trump's economic policy program is so far only broadly known. New speculation that global oil production would be limited initially drove up the prices for this raw material. In the evening, however, the arrows pointed down again.

The trend-setting crude oil Brent from the North Sea fell by 1.0 percent to $ 46.47 per barrel at the close of trading in the US.